Inventor · disambiguated record
Lee A. Flippin
Also filed as: FLIPPIN LEE A · FLIPPIN LEE ALLEN
45 granted patents·20 pending applications·1,058 citations·filing 1994–2021
99Inventor score
Top patents by PatentIndex Score
65 records- 0198US7323475B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2004·Granted Jan 29, 2008·97 cites·46 claims
- 0297US7629357B2Nitrogen-containing heteroaryl compounds and methods of user thereofFIBROGEN INC·Filed 2006·Granted Dec 8, 2009·38 cites·52 claims
- 0396US8017625B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2008·Granted Sep 13, 2011·42 cites·47 claims
- 0496US7863292B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2007·Granted Jan 4, 2011·28 cites·38 claims
- 0595US8765956B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2013·Granted Jul 1, 2014·19 cites·19 claims
- 0695US8278325B2Nitrogen-containing heteroaryl compounds and methods of use thereofAREND MICHAEL P·Filed 2011·Granted Oct 2, 2012·22 cites·24 claims
- 0795US7928120B2Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2007·Granted Apr 19, 2011·40 cites·36 claims
- 0895US7696223B2Pyrrolo- and Thiazolo-pyridine compounds, and methods of use thereofFIBROGEN INC·Filed 2007·Granted Apr 13, 2010·54 cites·32 claims
- 0994US8324405B2Chromene derivatives and use thereof as HIF hydroxylase activity inhibitorsHO WEN-BIN·Filed 2009·Granted Dec 4, 2012·36 cites·18 claims
- 1094US5688830ATreatment of neuropathic painSYNTEX INC·Filed 1997·Granted Nov 18, 1997·69 cites·7 claims
- 1193US10927081B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2018·Granted Feb 23, 2021·3 cites·46 claims
- 1293US8916585B2Nitrogen-containing heteroaryl compounds and methods of use thereofAREND MICHAEL P·Filed 2012·Granted Dec 23, 2014·16 cites·27 claims
- 1393US8759373B2Cyanoisoquinoline compounds and methods of use thereofAREND MICHAEL P·Filed 2012·Granted Jun 24, 2014·21 cites·33 claims
- 1493US8269008B2Oxazolopyridine and isoxazolopyridine derivatives for use in the treatment of HIF-mediated conditionsAREND MICHAEL P·Filed 2008·Granted Sep 18, 2012·37 cites·32 claims
- 1592US9695170B2Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylaseFIBROGEN INC·Filed 2016·Granted Jul 4, 2017·5 cites·32 claims
- 1692US8466172B2Stabilization of hypoxia inducible factor (HIF) alphaGUENZLER-PUKALL VOLKMAR·Filed 2010·Granted Jun 18, 2013·18 cites·8 claims
- 1792US5863924AAryl pyrimidine derivativesSYNTEX INC·Filed 1997·Granted Jan 26, 1999·141 cites·19 claims
- 1891US9271970B2Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylaseFIBROGEN INC·Filed 2014·Granted Mar 1, 2016·7 cites·30 claims
- 1991US8921389B2Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylaseNG DANNY·Filed 2012·Granted Dec 30, 2014·17 cites·26 claims
- 2090US9339527B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2014·Granted May 17, 2016·7 cites·20 claims
- 2190US8952160B2Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activityZHOU XIAOTI·Filed 2009·Granted Feb 10, 2015·18 cites·11 claims
- 2290US8217043B2Compounds and methods for their useDENG SHAOJIANG·Filed 2009·Granted Jul 10, 2012·31 cites·32 claims
- 2389US11680047B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2020·Granted Jun 20, 2023·1 cites·23 claims
- 2488US9387200B2Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activityFIBROGEN INC·Filed 2015·Granted Jul 12, 2016·5 cites·17 claims
- 2588US9174976B2Cyanoisoquinoline compounds and methods of use thereofFIBROGEN INC·Filed 2014·Granted Nov 3, 2015·9 cites·41 claims
- 2688US5958934AAryl pyrimidine derivatives and uses thereofSYNTEX INC·Filed 1997·Granted Sep 28, 1999·46 cites·7 claims
- 2787US10092558B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2016·Granted Oct 9, 2018·3 cites·20 claims
- 2887US8927591B2Thiochromene derivatives as HIF hydroxylase inhibitorsHO WEN-BIN·Filed 2009·Granted Jan 6, 2015·12 cites·37 claims
- 2987US8703795B2Thienopyridine compounds, and methods of use thereofTURTLE ERIC D·Filed 2006·Granted Apr 22, 2014·17 cites·14 claims
- 3085US9000006B2Thienopyridine compounds, and methods of use thereofFIBROGEN INC·Filed 2014·Granted Apr 7, 2015·7 cites·14 claims
- 3185US5753663APyrimidine derivativesSYNTEX INC·Filed 1996·Granted May 19, 1998·63 cites·19 claims
- 3284US9149476B2Thiochromene derivatives as HIF hydroxylase inhibitorsFIBROGEN INC·Filed 2014·Granted Oct 6, 2015·7 cites·37 claims
- 3384US6262078B1Phenoxymethyl piperidine derivatives for the treatment of neuropathic painSYNTEX LLC·Filed 2000·Granted Jul 17, 2001·14 cites·3 claims
- 3481US5739336A1,3,8-triaza- and 3,8-diaza-1-oxaspiro 4,5! decane derivativesSYNTEX INC·Filed 1996·Granted Apr 14, 1998·32 cites·17 claims
- 3580US9409892B24-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitorsFIBROGEN INC·Filed 2013·Granted Aug 9, 2016·6 cites·30 claims
- 3679US2021369702A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseFIBROGEN INC·Filed 2021·Application pending·0 cites
- 3778US5952331AAryl pyrimidine derivativesSYNTEX INC·Filed 1997·Granted Sep 14, 1999·25 cites·10 claims
- 3878US5412102AProcesses for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acidSYNTEX INC·Filed 1994·Granted May 2, 1995·15 cites·13 claims
- 3976US10765672B2Pharmaceutical formulations of a HIF hydroxylase inhibitorFIBROGEN INC·Filed 2018·Granted Sep 8, 2020·2 cites·6 claims
- 4075US11229637B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2020·Granted Jan 25, 2022·0 cites·12 claims
- 4173US6110937APhenoxymethyl piperidine derivatives for the treatment of neuropathic painSYNTEX INC·Filed 1998·Granted Aug 29, 2000·15 cites·15 claims
- 4271US10646482B2Nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2018·Granted May 12, 2020·0 cites·20 claims
- 4367US2015080425A1Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylaseKLAUS STEPHEN J·Filed 2014·Application pending·0 cites
- 4465US2017312268A1Methods for treating a neurological disorder in a subject using inhibitors of hypoxia-inducible factor (hif) proyl hydroxylaseFIBROGEN INC·Filed 2017·Application pending·0 cites
- 4564US2007155784A1Novel nitrogen-containing heteroaryl compounds and methods of use thereofFIBROGEN INC·Filed 2006·Application pending·0 cites
- 4663US2013245037A1Stabilization of Hypoxia Inducible Factor (HIF) AlphaGUENZLER-PUKALL VOLKMAR·Filed 2013·Application pending·0 cites
- 4763US2013203805A1Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylaseKLAUS STEPHEN J·Filed 2012·Application pending·0 cites
- 4862US2006270699A1Stabilization of hypoxia inducible factor (HIF) alphaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 4962US2006258660A1Stabilization of hypoxia inducible factor (HIF) alphaFIBROGEN INC·Filed 2006·Application pending·0 cites
- 5062US2006258702A1Stabilization of hypoxia inducible factor (HIF) alphaFIBROGEN INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →